Controlling drug delivery from coronary stents: are we aiming for the right targets?

Ther Deliv. 2015;6(6):705-20. doi: 10.4155/tde.15.25.

Abstract

In this review article, the currently employed or explored delivery concepts for local intravascular drug delivery with drug-eluting stents (DES) are discussed with a special emphasis on clinical evidence regarding the desired release profiles. Traditional concepts to control drug release from DES include diffusion through polymers, polymer degradation and erosion as well as dissolution of particulate drug. Published clinical studies do not always reveal fine mechanistic details. The long duration of release favored for DES and the short duration of release favored for drug-eluting balloons require further investigation in experimental studies and clinical trials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Coronary Restenosis / prevention & control*
  • Diffusion
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Drug-Eluting Stents*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / pharmacokinetics
  • Polymers / chemistry
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Polymers